Associated Papers
Defining the mutational profile of lower-risk myelodysplastic neoplasm patients with respect to disease progression using next-generation sequencing and pyrosequencing.
Adamska M et al.
Contemporary Oncology (poznan, Poland), 2023
Select a paper to view details